TXT2STOP: A randomised controlled trial of a novel smoking cessation intervention using mobile phone text-messaging

TXT2STOP:一项使用手机短信进行新型戒烟干预的随机对照试验

基本信息

项目摘要

We aim to test the effects of mobile phone based smoking cessation support on self reported smoking status verified using a biochemical test on a sample of saliva at six months. Smoking contributes to the death of one in two of those who continue to smoke past 35 years of age. Mobile phones allow personalised smoking cessation support programmes to be delivered inexpensively wherever the person is located. The New Zealand STOMP (stop smoking with mobile phones) trial found a doubling in quit rates at six weeks but provided no reliable data on long term effects. The Txt2stop intervention is based on the STOMP programme, modified for use in the UK. To modify the intervention, youth smoking cessation counsellors and 62 potential participants reviewed all text messages in a series of focus groups. We have already conducted a pilot study among 200 participants. We achieved 93% long term follow up. The short term results show a doubling of quit rate (24% vs. 10%). The Txt2stop trial among 5800 participants will establish the impact of mobile phone based smoking cessation support.
我们的目标是测试基于手机的戒烟支持对自我报告的吸烟状况的影响,该吸烟状况是通过对六个月唾液样本的生化测试进行验证的。 35 岁以上继续吸烟的人中有二分之一是因吸烟而死亡。无论人们身在何处,手机都可以以低廉的价格提供个性化的戒烟支持计划。新西兰 STOMP(用手机戒烟)试验发现,六周后戒烟率翻了一番,但没有提供长期影响的可靠数据。 Txt2stop 干预措施基于 STOMP 计划,并经过修改以供在英国使用。为了修改干预措施,青少年戒烟顾问和 62 名潜在参与者审查了一系列焦点小组中的所有短信。我们已经对 200 名参与者进行了试点研究。我们实现了 93% 的长期随访。短期结果显示戒烟率翻了一番(24% 比 10%)。 Txt2stop 试验在 5800 名参与者中进行,将确定基于手机的戒烟支持的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Caroline Free其他文献

Don’t Forget the Humble Text Message: 25 Years of Text Messaging in Health
不要忘记谦逊的短信:健康领域短信 25 年
  • DOI:
    10.2196/59888
  • 发表时间:
    2024-01-01
  • 期刊:
  • 影响因子:
    6.000
  • 作者:
    Rosie Dobson;Robyn Whittaker;Lorien C Abroms;Dale Bramley;Caroline Free;Hayden McRobbie;Melanie Stowell;Anthony Rodgers
  • 通讯作者:
    Anthony Rodgers
PPA_A_285442 1359..1371
PPA_A_285442 1359..1371
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
    P. Mishra;Ajay S Vamadevan;A. Roy;Rohit Bhatia;N. Naik;Sandeep Singh;Gideon Senyo Amevinya;Ernest Amoah Ampah;Yolanda Fernandez;Caroline Free;Amos Laar;D. Prabhakaran;Pablo Perel;Helena Legido
  • 通讯作者:
    Helena Legido
Assessing loss to follow-up in the MObile Technology for Improved Family Planning (MOTIF) randomised controlled trial
  • DOI:
    10.1186/s13063-017-2316-6
  • 发表时间:
    2017-12-01
  • 期刊:
  • 影响因子:
    2.000
  • 作者:
    Chris Smith;Christopher Jarvis;Caroline Free
  • 通讯作者:
    Caroline Free
Correction to: A randomized controlled trial of an intervention delivered by mobile phone app instant messaging to increase the acceptability of effective contraception among young people in Tajikistan
  • DOI:
    10.1186/s12978-018-0496-5
  • 发表时间:
    2018-03-26
  • 期刊:
  • 影响因子:
    3.400
  • 作者:
    Ona McCarthy;Irrfan Ahamed;Firuza Kulaeva;Ravshan Tokhirov;Salokhiddin Saibov;Marieka Vandewiele;Sarah Standaert;Baptiste Leurent;Phil Edwards;Melissa Palmer;Caroline Free
  • 通讯作者:
    Caroline Free
Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease
手机短信促进心血管疾病二级预防用药依从性
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    8.4
  • 作者:
    Julie Redfern;Qiang Tu;K. Hyun;Matthew A Hollings;N. Hafiz;Clara Zwack;Caroline Free;Pablo Perel;Clara K Chow
  • 通讯作者:
    Clara K Chow

Caroline Free的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Memory Reshaping for Depression: A Remote Digital Randomised Controlled Feasibility Trial
抑郁症记忆重塑:远程数字随机控制可行性试验
  • 批准号:
    MR/Y008545/1
  • 财政年份:
    2024
  • 资助金额:
    $ 216.34万
  • 项目类别:
    Research Grant
ExtraCECI: A cluster randomised controlled trial of community-based person-centred enhanced care for people with HIV/AIDS in Ghana
ExtraCECI:一项以社区为基础、以人为本的强化对加纳艾滋病毒/艾滋病患者护理的整群随机对照试验
  • 批准号:
    MR/Y019865/1
  • 财政年份:
    2024
  • 资助金额:
    $ 216.34万
  • 项目类别:
    Research Grant
Randomized controlled trial of in-person and virtual Symptom screening with Targeted Early Palliative care (STEP2) in patients with advanced cancer
对晚期癌症患者进行有针对性的早期姑息治疗 (STEP2) 进行现场和虚拟症状筛查的随机对照试验
  • 批准号:
    490098
  • 财政年份:
    2023
  • 资助金额:
    $ 216.34万
  • 项目类别:
    Operating Grants
Sedation Practice in Intensive Care Evaluation: Early Sedation with Dexmedetomidine in Older Ventilated Critically Ill Patients (SPICE-IV): A Randomised Double-Blind Placebo-Controlled Trial
重症监护评估中的镇静实践:老年通气危重患者早期使用右美托咪定镇静 (SPICE-IV):一项随机双盲安慰剂对照试验
  • 批准号:
    477888
  • 财政年份:
    2023
  • 资助金额:
    $ 216.34万
  • 项目类别:
    Operating Grants
Eliciting and incorporating patients' opinions about missing data in randomised controlled trials
征求并纳入患者对随机对照试验中缺失数据的意见
  • 批准号:
    2755760
  • 财政年份:
    2022
  • 资助金额:
    $ 216.34万
  • 项目类别:
    Studentship
MICA: Can interferon gamma prevent infection in critically ill patients at highest risk? A phase II randomised controlled trial.
MICA:γ 干扰素能否预防高风险危重患者的感染?
  • 批准号:
    MR/X004929/1
  • 财政年份:
    2022
  • 资助金额:
    $ 216.34万
  • 项目类别:
    Research Grant
MICA: A randomised, double blind, controlled mechanistic study of obinutuzumab versus rituximab in ANCA-associated vasculitis (ObiVas)
MICA:一项关于 obinutuzumab 与利妥昔单抗治疗 ANCA 相关血管炎 (ObiVas) 的随机、双盲、对照机制研究
  • 批准号:
    MR/W015544/1
  • 财政年份:
    2022
  • 资助金额:
    $ 216.34万
  • 项目类别:
    Research Grant
Intermittent preventive treatment in pregnancy with sulphadoxine-pyrimethamine plus dihydroartemisinin-piperaquine to reduce adverse pregnancy outcomes and prevent malaria in Papua New Guinea: a randomised controlled trial
在巴布亚新几内亚,用磺胺多辛-乙胺嘧啶加双氢青蒿素-哌喹对妊娠期进行间歇性预防治疗,以减少不良妊娠结局并预防疟疾:一项随机对照试验
  • 批准号:
    nhmrc : 2000780
  • 财政年份:
    2022
  • 资助金额:
    $ 216.34万
  • 项目类别:
    Clinical Trials and Cohort Studies Grants
Personalized integrated COgnitive-Sensory-MOtor training(iCOSMO) intervention to improve arm and hand function after chronic stroke: a pilot randomised controlled trial
个性化综合认知-感觉-运动训练(iCOSMO)干预以改善慢性中风后手臂和手部功能:一项试点随机对照试验
  • 批准号:
    460604
  • 财政年份:
    2022
  • 资助金额:
    $ 216.34万
  • 项目类别:
Parent-Delivered Early Language Intervention for Children with Down Syndrome: A Randomised Controlled Feasibility Trial
家长对唐氏综合症儿童进行早期语言干预:随机对照可行性试验
  • 批准号:
    ES/V016946/1
  • 财政年份:
    2022
  • 资助金额:
    $ 216.34万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了